// App-Quantinova.ai

2631 : Validation of Clinically Relevant Improvement in Children and Adolescents with cSLE

Researchers

Presenter

  • Pinar Ozge Avar Aydin

Principal Investigators

  • Michael J. Holland

  • Simone Appenzeller

  • Stacy P. Ardoin

  • Tadej Avcin

  • Michael W. Beresford

  • Brian M. Feldman

  • Francisco Flores

  • Marisa S. Klein-Gitelman

  • Beatrice Goilav

  • Raju Khubchandani

  • Deborah M. Levy

  • Angelo Ravelli

  • Nicolino Ruperto

  • Clovis A Silva

  • Scott E. Wenderfer

  • Jun Ying

  • Hermine I. Brunner

Medical Centers

  • Cincinnati Children's Hospital Medical Center, Cincinnati, OH

  • Pediatric Residency Program, Cincinnati Childrens Hospital Medical Center, Cincinnati, OH

  • Pediatric Rheumatology Unit, State University of Campinas, Sao Paulo, Brazil

  • Istituto Giannina Gaslini - Pediatria II, Reumatologia - PRINTO, GENOA, Italy

  • On Behalf of the UK JSLE Study Group, Liverpool, United Kingdom

  • Hospital for Sick Children, Toronto, ON, Canada

  • Division of Nephrology, Cincinnati Childrens Hospital Medical Center, Cincinnati, OH

  • Division of Pediatric Rheumatology/PDD PTD, Lurie Children's Hospital of Chicago/Northwestern University, Chicago, IL

  • Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY

  • Department of Paediatrics, Jaslok Hospital and Research Center, Mumbai, India

  • University of Toronto, The Hospital for Sick Children, Toronto, ON, Canada

  • University of Genoa, Istituto Giannina Gaslini, Genoa, Italy

  • Istituto Giannina Gaslini, Genoa, Italy

  • Rheumatology Unit, Instituto da Criança, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil, São Paulo, Brazil

  • Baylor College of Medicine/Texas Children's Hospital, Houston, TX

  • Center for Biostatistical Services, University of Cincinnati College of Medicine, Cincinnati, OH

Locations

  • United States

  • Brazil

  • Italy

  • United Kingdom

  • Canada

  • India

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A